Typhoid Superbug Rapidly Spreads Across Globe, Threatening Antibiotic Effectiveness

A rapidly evolving strain of the typhoid bacterium is developing extensive resistance to antibiotics, raising urgent concerns among global health experts. New research published in The Lancet Microbe reveals that Salmonella enterica serovar Typhi (S Typhi), the cause of typhoid fever, is not just persisting but becoming alarmingly drug-resistant and replacing non-resistant strains at an unprecedented pace.

Researchers sequenced the genomes of 3,489 S Typhi samples collected from 2014 to 2019 in Nepal, Bangladesh, Pakistan, and India—countries where typhoid remains a pervasive public health issue. Their analysis uncovered a sharp rise in extensively drug-resistant (XDR) Typhi. This variant is now resistant to widely used antibiotics such as ampicillin, chloramphenicol, trimethoprim/sulfamethoxazole, as well as newer drugs like fluoroquinolones and third-generation cephalosporins—leaving very few treatment options.

Even more concerning, XDR Typhi’s resistance genes are spreading, with nearly 200 instances of international transmission documented since 1990. Most exported cases have reached Southeast Asia, East and Southern Africa, and have even been identified in the United Kingdom, the United States, and Canada. Health specialists, such as Stanford University’s Jason Andrews, have described the situation as “a real cause for concern,” highlighting the pressing need to ramp up prevention and monitoring efforts.

With azithromycin currently the only effective oral drug remaining, researchers warn that emerging resistance to this last resort antibiotic could lead to an era where all oral antimicrobials for typhoid are rendered ineffective. If left untreated, typhoid can be fatal in up to 20% of cases, and the world still registers approximately 11 million cases each year. Vaccination offers a promising avenue—particularly with the successful rollout of routine immunization in Pakistan—but access remains uneven. Studies suggest that widespread vaccination in urban areas could prevent up to 36% of cases and deaths, underscoring the need for global expansion of vaccination programs.

Antibiotic resistance now kills more people than HIV/AIDS or malaria worldwide. As extremely drug-resistant typhoid strains continue to appear and disperse globally, experts caution that only a coordinated response—including increased vaccine access, improved sanitation, and investment in new antibiotics—can avert a potential health catastrophe.

“The recent emergence of XDR and azithromycin-resistant S Typhi creates greater urgency for rapidly expanding prevention measures, including use of typhoid conjugate vaccines in typhoid-endemic countries,” the study’s authors urge.

Disclaimer: This article is based on findings published in peer-reviewed scientific journals and statements from medical experts. The information is intended for general news reporting purposes and should not be used as a substitute for professional medical advice. If you have health concerns, please consult a qualified healthcare provider.